Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 70518-4531

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 70518-4531). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Metoprolol Succinate 25 mg extended-release film-coated tablets packaging label. The label indicates a quantity of 30 tablets, with an oval white tablet shape shown. It is repackaged by RemedyRepack Inc., Indiana, PA, with storage instructions and the NDC 70518-4531-00. The label includes warnings to keep out of reach of children and recommended storage temperatures.*

FDA Label Image

Meto-figure.jpg (Meto Figure)

Forest plot figure titled "Results for Subgroups in MERIT-HF," displaying relative risk and 95% confidence intervals for total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure. The plot compares metoprolol succinate extended-release tablets against placebo in various subgroups categorized by geography, NYHA class, ejection fraction, ischemic etiology, sex, race, prior myocardial infarction, diabetes, hypertension, and heart rate.*

FDA Label Image

Meto-structure.jpg (Meto Structure)

Chemical structure of metoprolol succinate, displaying the molecular arrangement of the metoprolol moiety along with the succinate component as part of the salt form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.